当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3220969
自主品牌
已选条件
-
T6321TofacitinibTasocitinib；CP-690550；托法替尼
Tofacitinib is an oral, small molecule inhibitor of Janus kinases that is used to treat moderate-to-severe rheumatoid arthritis.
价 格：￥电议型 号：T6321产 地：中国大陆
-
T2398Tofacitinib Citrate柠檬酸托法替尼；枸橼酸托法替尼；Tasocitinib citrate；Tofacitinib (CP-690550) Citrate；CP-690550 cit
Tofacitinib citrate is a a potent, cell-permeable inhibitor of JAK1/2/3 (IC50s: 1/20/112 nM).
价 格：￥电议型 号：T2398产 地：中国大陆
-
T2398Tofacitinib CitrateTofacitinib Citrate,CP-690550 citrate,Tasocitinib citrate
Tofacitinib citrate is a a potent, cell-permeable inhibitor of JAK1/2/3 (IC50s: 1/20/112 nM).
价 格：￥电议型 号：T2398产 地：美洲
-
T6321TofacitinibTofacitinib,CP-690550,Tasocitinib
Tofacitinib is an oral, small molecule inhibitor of Janus kinases that is used to treat moderate-to-severe rheumatoid arthritis.
价 格：￥电议型 号：T6321产 地：美洲
-
T72406Tofacitinib Prodrug-1；化合物 Tofacitinib Prodrug-1Tofacitinib Prodrug-1
Tofacitinib Prodrug-1 is an effective and oral active prodrug to mitigate the systemic adverse effects of Tofacitinib. Tofacitinib Prodrug-1 can effectively attenuate the oxazolone-induced colitis in mice model with low toxicity. Tofacitinib Prodrug-1 is a potential drug candidate for the treatment of ulcerative colitis [1] .
价 格：￥电议型 号：T72406产 地：中国大陆
-
T70168Tofacitinib HCl；化合物 Tofacitinib HClTofacitinib HCl
Tofacitinib HCl, also known as tasocitinib, CP-690550, is a Janus kinase (JAK) inhibitor. Tofacitinib HCl modulates the signaling pathway at the point of JAKs, preventing the phosphorylation and activation of STATs. JAK enzymes transmit cytokine signaling through pairing of JAKs (e.g., JAK1/JAK3, JAK1/JAK2, JAK1/TyK2, JAK2/JAK2). Tofacitinib HCl inhibited the in vitro activities of JAK1/JAK2, JAK1/JAK3, and JAK2/JAK2 combinations with IC50 of 406, 56, and 1377 nM, respectively.
价 格：￥电议型 号：T70168产 地：中国大陆
-
T69958Tofacitinib maleate；化合物 Tofacitinib maleateTofacitinib maleate
Tofacitinib maleate, also known as tasocitinib, CP-690550, is a Janus kinase (JAK) inhibitor. Tofacitinib maleate modulates the signaling pathway at the point of JAKs, preventing the phosphorylation and activation of STATs. JAK enzymes transmit cytokine signaling through pairing of JAKs (e.g., JAK1/JAK3, JAK1/JAK2, JAK1/TyK2, JAK2/JAK2). Tofacitinib maleate inhibited the in vitro activities of JAK1/JAK2, JAK1/JAK3, and JAK2/JAK2 combinations with IC50 of 406, 56, and 1377 nM, respectively.
价 格：￥电议型 号：T69958产 地：中国大陆
-
T6321Tofacitinib；托法替尼Tasocitinib|||CP-690550；托法替尼|||Tasocitinib|||CP-690550
Tofacitinib (Tasocitinib) is an oral, small molecule inhibitor of Janus kinases that is used to treat moderate-to-severe rheumatoid arthritis.
价 格：￥电议型 号：T6321产 地：中国大陆
-
T31074CP-690550A；化合物 T31074Tofacitinib metabolite M2|||CP-690,550A|||UNII-Q7ZOK859UK；Tofacitinib metabolit
Cp-690550a is a novel JAK3 inhibitor, which is used to treat rheumatoid arthritis, graft rejection, psoriasis, and other immune-mediated diseases.
价 格：￥电议型 号：T31074产 地：中国大陆
-
T2398Tofacitinib Citrate；枸橼酸托法替尼CP-690550 citrate|||Tasocitinib citrate|||Tofacitinib (CP-690550) Citrate
Tofacitinib Citrate (CP-690550 citrate) is a a potent, cell-permeable inhibitor of JAK1/2/3 (IC50s: 1/20/112 nM).
价 格：￥电议型 号：T2398产 地：中国大陆
-
T13427(3S,4R)-Tofacitinib；(3S,4R)-托法替尼(3S,4R)-Tofacitinib
(3S,4R)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib is a JAK3 inhibitor(IC50 : 1 nM).
价 格：￥电议型 号：T13427产 地：中国大陆
-
T13426L(3S,4S)-Tofacitinib(3S,4S)-托法替尼(3S,4S)-托法替尼
(3S,4S)-Tofacitinib, a less active enantiomer of tofacitinib, is a Janus kinases inhibitor.
价 格：￥电议型 号：T13426L产 地：中国大陆
